Breakout results

Growth on every line at once: revenue up more than 20%, profit up more than 25% and margins expanding — all three in the same results filing, inside the window. One growth number is common; all three together is the bar. The mirror view holds the companies shrinking on every line in the same period.

In the same window: 86 companies with deteriorating results. See the other side →
CompanyWhy it’s here — the filingReaction 1d / 1w / 1mPriceMcapP/EROCERev YoY
Aditya VisionSpeciality RetailAditya Vision Q1 PAT up 40% YoY at Rs 77.22 cr; MSKA appointed as auditor31 Jul 2026Revenue Growth 20pctPat Growth 25pctEbitda Margin Expansion-0.8% -1.6% ₹5977,704 Cr78.3vs 22.417.4%+36.6%
Leela Palaces HotelHotels & ResortsStrong Q1 FY27 Results - Revenue up 28%, EBITDA up 41%, PAT up 460%31 Jul 2026Revenue Growth 20pctPat Growth 25pctEbitda Margin Expansion+7.5% +10.0% ₹56418,834 Cr26.6vs 22.95.9%+55.9%
Kajaria CeramicsCeramicsQ1 FY27 results: revenue up 20%, PAT jumps 56%; Rs 165 cr expansion approved31 Jul 2026Revenue Growth 20pctPat Growth 25pctEbitda Margin Expansion×2+1.5% +3.3% ₹1,21019,274 Cr39.6vs 26.720.3%+15.8%
Shadowfax Technologies LLogistics Solution ProviderShadowfax Q1 FY27: Revenue up 65% YoY to Rs 1,358 Cr, PAT hits record Rs 65 Cr31 Jul 2026Revenue Growth 20pctPat Growth 25pctEbitda Margin Expansion+9.0% +12.9% ₹25514,848 Cr109.4vs 16.25.7%
Yasho IndustriesSpecialty ChemicalsYasho Industries Q1 FY27 PAT jumps to Rs 36.4 cr, revenue up 59% YoY31 Jul 2026Revenue Growth 20pctPat Growth 25pctEbitda Margin Expansion+22.5% +33.9% ₹4,3615,258 Cr156.9vs 30.04.3%-35.5%
IndegeneHealthcare Research Analytics & TechnologyIndegene Q1 FY27: Revenue up 39.7% YoY, PAT jumps 45.9% QoQ30 Jul 2026Revenue Growth 20pctPat Growth 25pctEbitda Margin Expansion+5.8% +10.5% ₹56813,658 Cr37.3vs 28.814.9%+24.8%
Aarti IndustriesSpecialty ChemicalsAarti Industries Q1 FY27: Revenue up 37%, PAT more than triples YoY30 Jul 2026Revenue Growth 20pctPat Growth 25pctEbitda Margin Expansion+1.0% +5.1% ₹52719,113 Cr35.3vs 30.04.4%+5.0%
GNG ElectronicsComputers Hardware & EquipmentsGNG Electronics Q1 FY27: Revenue up 33%, PAT up 56% YoY30 Jul 2026Revenue Growth 20pctPat Growth 25pctEbitda Margin Expansion-3.9% +3.3% ₹6066,908 Cr46.0vs 23.118.7%+48.1%
Deepak Fertilizers & PetrCommodity ChemicalsDFPCL Q1 FY27: Net Profit Doubles to Rs 490 Cr, Revenue Up 22%30 Jul 2026Revenue Growth 20pctPat Growth 25pctEbitda Margin Expansion×3-5.0% -5.9% ₹1,44818,280 Cr32.5vs 17.58.4%+0.2%
Tbo TekTour Travel Related ServicesRevised Q1 FY27 Shareholder Letter: 37% GTV Growth, Margin Expansion29 Jul 2026Revenue Growth 20pctPat Growth 25pctEbitda Margin Expansion×2+0.5% +5.9% ₹1,69418,392 Cr79.5vs 37.613.1%+43.5%
V-guard IndHousehold AppliancesV-Guard Q1 FY27: Revenue up 23%, PAT nearly doubles YoY29 Jul 2026Revenue Growth 20pctPat Growth 25pctEbitda Margin Expansion+8.2% +9.7% ₹33214,484 Cr49.9vs 57.615.5%+30.9%
City Union BankPrivate Sector BankCity Union Bank Q1 FY27 PAT up 25 percent to Rs 383 Cr, NII up 31 percent, GNPA falls to 1.73 percent28 Jul 2026Revenue Growth 20pctPat Growth 25pctEbitda Margin Expansion+4.2% -5.7% ₹21716,087 Cr23.2vs 24.9
Pine LabsFinancial Technology (Fintech)Pine Labs Q1 FY27: Revenue up 20% YoY at 737 Cr, PAT jumps 4x28 Jul 2026Revenue Growth 20pctPat Growth 25pctEbitda Margin Expansion-3.0% +5.0% ₹15718,001 Cr117.0vs 90.92.2%+7.8%
TTK PrestigeHousehold AppliancesTTK Prestige Q1 PAT jumps 89% YoY to Rs 66.4 cr on strong revenue growth28 Jul 2026Revenue Growth 20pctPat Growth 25pctEbitda Margin Expansion+4.0% -2.9% ₹5868,030 Cr57.6vs 57.610.2%-12.5%
Balaji AminesSpecialty ChemicalsQ1 FY27 Results: Revenue up 32 percent, PAT jumps 81 percent YoY (Standalone)27 Jul 2026Revenue Growth 20pctPat Growth 25pctEbitda Margin Expansion×2-1.7% -8.7% ₹2,0726,713 Cr35.1vs 30.09.9%+15.9%
Supreme PetrochemPetrochemicalsQ1 FY27: PAT jumps 192% YoY, Rs 325 Cr capex announced27 Jul 2026Revenue Growth 20pctPat Growth 25pctEbitda Margin Expansion-3.8% -8.4% ₹69513,074 Cr47.0vs 20.617.6%+43.6%
Senores Pharmaceuticals LPharmaceuticalsQ1 FY27 Results: Revenue up 36% YoY, PAT up 44%, EBITDA grows 87%27 Jul 2026Revenue Growth 20pctPat Growth 25pctEbitda Margin Expansion-4.3% -4.5% ₹1,5186,990 Cr49.8vs 28.513.5%+8.3%
Sandur Mang & Iron Ores LIron & SteelFY26 Annual Report: PAT rises 40% to Rs 658 cr, net debt free27 Jul 2026Revenue Growth 20pctPat Growth 25pctEbitda Margin Expansion+3.7% +9.7% ₹2009,707 Cr13.8vs 16.620.9%+22.6%
Onesource Specl Pharma LPharmaceuticalsOneSource Q1FY27 revenue up 37% YoY, EBITDA up 39%, FY28 guidance reaffirmed24 Jul 2026Revenue Growth 20pctEbitda Margin ExpansionPat Growth 25pct+4.6% -6.6% ₹1,53217,561 Cr-1.4%+14.0%
Neogen ChemicalsSpecialty ChemicalsNeogen Chemicals Q1 FY27: Revenue up 37%, PAT rises 37% YoY; board clears Rs 600 crore fundraise24 Jul 2026Revenue Growth 20pctPat Growth 25pctEbitda Margin Expansion-1.6% -2.1% ₹2,2225,862 Cr194.2vs 30.02.4%+18.2%
Vmart RetailDiversified RetailV-Mart Q1 PAT up 42% at Rs 47 cr, revenue grows 23% YoY24 Jul 2026Revenue Growth 20pctPat Growth 25pctEbitda Margin Expansion×2-5.9% +2.4% ₹8396,663 Cr33.4vs 31.59.8%+20.3%
Page 2 of 2Previous
How this list is built

A company appears when an NSE/BSE filing inside the last 30 days carries one of these classifier signals (minimum importance: Medium): Revenue Growth 20pct, Pat Growth 25pct, Ebitda Margin Expansion. Each row shows the latest qualifying filing; the reaction columns are the stock’s measured move 1 day, 1 week and 1 month after that filing.

MarketPing publishes facts, filings and measured history only — nothing on this page is investment advice, a recommendation or a rating.